The interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer's disease.

Jazvinscak Jembrek, Maja; Slade, Neda; Hof, Patrick R; Simic, Goran

Jazvinscak Jembrek, Maja; Slade, Neda; Hof, Patrick R; Simic, Goran.

Afiliação

Jazvinscak Jembrek M; Division of Molecular Medicine, Ruder Boskovic Institute, Zagreb, Croatia; Department of Psychology, Catholic University of Croatia, Zagreb, Croatia. Electronic address: Maja.Jazvinscak.Jembrek@irb.hr.
Slade N; Division of Molecular Medicine, Ruder Boskovic Institute, Zagreb, Croatia.
Hof PR; Fishberg Department of Neuroscience, Ronald M. Loeb Center for Alzheimer's Disease, and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Simic G; Department for Neuroscience, Croatian Institute for Brain Research, University of Zagreb Medical School, Zagreb, Croatia.

Prog Neurobiol ; 168: 104-127, 2018 09.

Article em En | MEDLINE | ID: mdl-29733887

Assuntos

Doença de Alzheimer/metabolismo; Doença de Alzheimer/terapia; Peptídeos beta-Amiloides/metabolismo; Proteína Supressora de Tumor p53/metabolismo; Proteínas tau/metabolismo; Animais; Humanos

Palavras-chave

Alzheimer's disease; Aß; Neuronal apoptosis; Oxidative stress; Tau; p53

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Peptídeos beta-Amiloides / Proteína Supressora de Tumor p53 / Proteínas tau / Doença de Alzheimer Tipo de estudo: Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Prog Neurobiol Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google